These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21216841)

  • 21. Genetic polymorphisms in the DNA repair gene, XRCC1 associate with non-Hodgkin lymphoma susceptibility: A systematic review and meta-analysis.
    Li Y; Bai O; Cui J; Li W
    Eur J Med Genet; 2016 Feb; 59(2):91-103. PubMed ID: 26723520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma.
    Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C
    Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Polymorphisms of X-Ray Repair Cross Complementing Group 1 Gene and Pancreatic Cancer Risk: a Systematic Review with Meta-Analysis.
    Chen J; Wang H; Li Z
    Pathol Oncol Res; 2019 Jul; 25(3):897-904. PubMed ID: 29285737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis.
    Cui Z; Yin Z; Li X; Wu W; Guan P; Zhou B
    BMC Cancer; 2012 Feb; 12():71. PubMed ID: 22339849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
    Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
    Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India.
    Ghosh S; Ghosh S; Bankura B; Saha ML; Maji S; Ghatak S; Pattanayak AK; Sadhukhan S; Guha M; Nachimuthu SK; Panda CK; Maity B; Das M
    Tumour Biol; 2016 Jul; 37(7):9139-49. PubMed ID: 26768611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis.
    Chen B; Zhou Y; Yang P; Wu XT
    Mol Biol Rep; 2012 Feb; 39(2):1305-13. PubMed ID: 21604176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A meta-analysis of an association between the XRCC1 polymorphisms and gliomas risk.
    Li M; Zhou Q; Tu C; Jiang Y
    J Neurooncol; 2013 Feb; 111(3):221-8. PubMed ID: 23238971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
    Gu X; Sun H; Chang L; Sun R; Yang H; Zhang X; Cong X
    Neural Regen Res; 2013 Sep; 8(26):2468-77. PubMed ID: 25206557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis.
    Huang Y; Li L; Yu L
    Mutagenesis; 2009 Jul; 24(4):331-9. PubMed ID: 19465687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
    Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis.
    Fang Z; Chen F; Wang X; Yi S; Chen W; Ye G
    PLoS One; 2013; 8(5):e64001. PubMed ID: 23704969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. XRCC1 Gene Polymorphisms and Breast Cancer Risk: A Systematic Review and Meta- Analysis Study.
    Sanjari Moghaddam A; Nazarzadeh M; Sanjari Moghaddam H; Bidel Z; Keramatinia A; Darvish H; Mosavi-Jarrahi A
    Asian Pac J Cancer Prev; 2016; 17(S3):323-30. PubMed ID: 27165246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
    Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
    Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Li C; Xiang X; Zhou Y
    Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer.
    Mandegari M; Dastgheib SA; Asadian F; Shaker SH; Tabatabaie SM; Kargar S; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2221-2236. PubMed ID: 34319046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
    Zhang H; Liu H; Jiang G
    PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis.
    Zhang F; Wu JH; Zhao W; Liu HT
    Tumour Biol; 2013 Oct; 34(5):2659-64. PubMed ID: 23636799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The polymorphism of XRCC1 and coronary artery disease risk: a meta-analysis.
    Guo SJ; Zhou YT; Liu WY; Zuo QN; Li XH
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1559-1567. PubMed ID: 28429350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating the association between XRCC1 gene polymorphisms and susceptibility to gastric cancer.
    Chen S; Zhu XC; Liu YL; Wang C; Zhang KG
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.